- Company Overview for SDS THERAPEUTICS LIMITED (12719780)
- Filing history for SDS THERAPEUTICS LIMITED (12719780)
- People for SDS THERAPEUTICS LIMITED (12719780)
- More for SDS THERAPEUTICS LIMITED (12719780)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
08 Jul 2024 | CS01 | Confirmation statement made on 4 July 2024 with no updates | |
14 Mar 2024 | AA | Accounts for a small company made up to 31 July 2023 | |
05 Mar 2024 | TM01 | Termination of appointment of Francesco De Rubertis as a director on 17 January 2024 | |
05 Mar 2024 | TM01 | Termination of appointment of David John Grainger as a director on 17 January 2024 | |
06 Nov 2023 | PSC08 | Notification of a person with significant control statement | |
06 Nov 2023 | PSC07 | Cessation of Medicxi Iii Lp as a person with significant control on 18 December 2020 | |
04 Jul 2023 | CS01 | Confirmation statement made on 4 July 2023 with no updates | |
10 May 2023 | AA | Accounts for a small company made up to 31 July 2022 | |
05 Jul 2022 | CS01 | Confirmation statement made on 4 July 2022 with no updates | |
24 Feb 2022 | AA | Accounts for a small company made up to 31 July 2021 | |
29 Oct 2021 | AP04 | Appointment of The Cambridge Partnership Limited as a secretary on 5 July 2020 | |
05 Jul 2021 | CS01 | Confirmation statement made on 4 July 2021 with updates | |
02 Feb 2021 | SH02 | Sub-division of shares on 18 December 2020 | |
29 Jan 2021 | SH01 |
Statement of capital following an allotment of shares on 27 January 2021
|
|
28 Jan 2021 | PSC02 | Notification of Medicxi Iii Lp as a person with significant control on 18 December 2020 | |
18 Jan 2021 | AP01 | Appointment of Professor James Huntington as a director on 18 December 2020 | |
13 Jan 2021 | AP01 | Appointment of Dr Christine Janet Martin as a director on 18 December 2020 | |
13 Jan 2021 | PSC07 | Cessation of David John Grainger as a person with significant control on 18 December 2020 | |
13 Jan 2021 | AP01 | Appointment of Mr Francesco De Rubertis as a director on 18 December 2020 | |
13 Nov 2020 | AD01 | Registered office address changed from Dorothy Hodgkin Building Babraham Research Campus Babraham Cambridge CB22 3AT United Kingdom to C/O the Cambridge Partnership Limited the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH on 13 November 2020 | |
05 Jul 2020 | NEWINC |
Incorporation
Statement of capital on 2020-07-05
|